Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2006 | 03-2006 | 12-2005 | 09-2005 | 06-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,287 | 28,351 | 67,072 | 41,071 | 26,342 |
| Marketable Securities | 135,507 | 132,005 | 98,983 | 85,282 | 42,211 |
| Receivables | 1,618 | 1,170 | 3,287 | 1,802 | 1,997 |
| Other current assets | 2,785 | 3,259 | 2,561 | 1,421 | 2,734 |
| TOTAL | $158,197 | $164,785 | $171,903 | $129,576 | $73,284 |
| Non-Current Assets | |||||
| PPE Net | 6,434 | 4,615 | 4,156 | 4,084 | 4,130 |
| Investments And Advances | 1,500 | 9,260 | 7,406 | 1,766 | 93 |
| Other Non-Current Assets | 541 | 539 | 538 | 536 | 535 |
| TOTAL | $8,475 | $14,414 | $12,100 | $6,386 | $4,758 |
| Total Assets | $166,672 | $179,199 | $184,003 | $135,962 | $78,042 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,574 | 6,548 | 10,238 | 8,400 | 7,544 |
| Other current liabilities | 213 | 831 | 984 | 48 | 1,100 |
| TOTAL | $38,638 | $33,397 | $34,802 | $8,448 | $8,644 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 26,851 | 26,018 | 23,580 | N/A | N/A |
| Other Non-Current Liabilities | 77 | 54 | 49 | 44 | 38 |
| TOTAL | $23,863 | $31,184 | $36,469 | $44 | $38 |
| Total Liabilities | $62,501 | $64,581 | $71,271 | $8,492 | $8,682 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,913 | 25,576 | 25,451 | 24,493 | 21,314 |
| Common Shares | 33 | 33 | 33 | 32 | 28 |
| Retained earnings | -205,711 | -191,383 | -188,740 | -156,043 | -145,300 |
| Other shareholders' equity | -344 | -289 | -4,646 | -5,088 | -1,772 |
| TOTAL | $104,171 | $114,618 | $112,732 | $127,470 | $69,360 |
| Total Liabilities And Equity | $166,672 | $179,199 | $184,003 | $135,962 | $78,042 |